Syndax Pharmaceuticals (SNDX) Research Hub

Syndax Pharmaceuticals (SNDX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 13.22 USD (-1.34%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.88, market cap 1.95B. This hub links to the full technical, earnings and options research available for SNDX.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close13.22 USD (-1.34%)
52-week range12.785 USD – 25.17 USD
Trend regimeRange
14-day RSI16 (Oversold)
Trailing P/E-7.88
Market cap1.95B
Dividend yield0.00%
Next earnings2026-08-03

Available research for SNDX

Earnings

SNDX earnings date and last-quarter result: next report 2026-08-03, last quarter beat, P/E -7.88. Updated 2026-07-23.

Options: Covered Call

Covered Call on SNDX: how it works, illustrative setup around the real 13.22 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on SNDX: how it works, illustrative setup around the real 13.22 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on SNDX: how it works, illustrative setup around the real 13.22 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

SNDX technical analysis: range, last 13.22 USD, RSI 16, 52w range 12.785 USD–25.17 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is SNDX in?

Syndax Pharmaceuticals (SNDX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is SNDX in an uptrend or downtrend?

As of 2026-10-26, SNDX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is SNDX's trailing P/E ratio?

SNDX's trailing P/E is -7.88, with a market cap of 1.95B. See the earnings research page for full valuation detail.

When does SNDX next report earnings?

SNDX is next scheduled to report earnings on 2026-08-03.